Filing Details

Accession Number:
0001209191-21-002832
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-08 19:29:34
Reporting Period:
2021-01-06
Accepted Time:
2021-01-08 19:29:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070494 Acadia Pharmaceuticals Inc ACAD Pharmaceutical Preparations (2834) 061376651
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1772518 Elena Ridloff C/o Acadia Pharmaceuticals Inc.
12830 El Camino Real, Suite 400
San Diego CA 92130
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-06 2,722 $0.00 4,917 No 4 M Direct
Common Stock Disposition 2021-01-06 1,016 $53.34 3,901 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-01-06 1,016 $0.00 1,016 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,873 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  2. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
  3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  4. The restricted stock units vest in four equal annual installments beginning January 6, 2021.